INVITED SPEAKERS ROSWELL PARKFACULTY Tampa, FL Moffitt Cancer Center Department ofMalignantHematology Lymphoma Section Assistant Member Julio Chavez,MD Transplant Center Director, BloodandMarrow Internal Medicine Professor ofOncologyand Philip McCarthy,MD Department ofMedicine Blood andMarrowTransplant Assistant ProfessorofOncology Christine Ho,MD Department ofImmunology Department ofMedicine & Myeloma Clinical Chief,Lymphoma Professor ofOncology Ilizaliturri, MD Hernandez- Francisco and LaboratoryMedicine Department ofPathology Assistant ProfessorofOncology Fadi Habib,MD Department ofMedicine Leukemia Service Director, Ambulatory Director ofMDS Associate ProfessorofOncology Elizabeth Griffiths,MD Laboratory Medicine Department ofPathologyand Cytogenetics Lab Laboratory Director, Associate ProfessorofOncology AnneMarie Block,PhD,FACMG

Cleveland, OH Cleveland Clinic & MedicalOncology Fellowship Program Director, Hematology College ofMedicine Cleveland ClinicLerner Associate ProfessorofMedicine Hetty Carraway,MD,MBA,FACP Laboratory Medicine Department ofPathologyand Assistant ProfessorofOncology Jerry Wong,MD,PhD Department ofMedicine Lymphoma &MyelomaDivision Assistant ProfessorofOncology Pallawi Torka,MD Department ofMedicine Leukemia Service Assistant ProfessorofOncology Swapna Thota,MD Laboratory Medicine Department ofPathologyand Research Coordinator Cytogenetics Laboratoryand Assistant DirectorofClinical Assistant ProfessorofOncology Sheila N.JaniSait,PhD Laboratory Medicine Department ofPathology& Hematology Chief, DivisionofDiagnostic Assistant ProfessorofOncology Vishala Neppalli,MD Department ofMedicine

[email protected] If youhaveanyquestions,contactDeniseHammellat deducted foranyregistrationcancellations. August 15,2017.Therewillbea$10administrativefee notified. Norefundswillbeissuedforcancellationsafter cancel theprogramforanyreason.Registrantswillbe Roswell ParkCancerInstitutereservestherightto Residents, Fellows,Students,RetiredPhysicians Pharmaceutical IndustryEmployees the registration deskforvalidation. Harrison PlaceParkingGarage. Bringyourparkingticketto Syracuse 13202.Parkingwillbe validatedonlyatthe in theHarrisonPlaceParkingGarage, 100HarrisonPlace, Parking attheMarriottSyracuse Downtownisavailable PARKING 100 EastOnondagaStreetSyracuse,NY13202 Marriott Syracuse Downtown LOCATION NPs, PAsandOtherHealthcareProfessionals Physicians andpharmacists Registration Fee:(includesbreakfast,break,andlunch) WWW.ROSWELLPARK.EDU/CMECONFERENCES REGISTER ON-LINEAT: SATURDAY, AUGUST19,2017 HEMATOLOGICAL MALIGNANCIESCONFERENCE2017 REGISTRATION FEES

.

or . (716) 845-5706. . . $165.00 $65.00 $35.00 $10.00

Elm & Carlton Streets Buffalo, NY 14263 RETURN SERVICE REQUESTED

40476 (7/17) MALIGNANCIES CONFERENCE WWW.ROSWELLPARK.EDU/CMECONFERENCES Saturday, August 19, 2017 Incorporating Targeted Therapies Marriott Syracuse Downtown HEMATOLOGICAL 100 East Onondaga Street in Blood-RelatedDisorders 8:00 am–3:00pm REGISTER ONLINEAT Syracuse, NY 13202 -2017-

PROGRAM HEMATOLOGICAL MALIGNANCIES - 2017 8:00 AM – 3:00 PM 7:30 am Registration DESCRIPTION LUNCH BREAK 8:00 Introduction and Opening Remarks • Recognize how gene profiling and gene sequencing studies 11:30 Hematopathology Round Table Case Discussion This program is designed for hematologists, oncologists, Francisco Hernandez-Ilizaliturri, MD are improving our knowledge of the biology of MDS. pathologists, nurse practitioners, physician assistants, and Session Chair: Vishala Neppalli, MD other providers specializing in hematology/oncology practice. LYMPHOMA New, clinically-relevant research findings are reported each • Identify biomarkers that can predict the clinical course of Participating Faculty: Program Chair: Francisco Hernandez-Ilizaliturri, MD year, and while community oncologists may learn about patients with different subtypes of MPD. • AnneMarie W. Block, PhD, FACMG these findings in a timely manner, it can take months before • Fadi Habib. MD 8:10 Clinical Practice Changes in the Management strategies are developed to effectively put this new knowledge • Select and perform appropriate diagnostic modalities for an • Sheila N. Jani Sait, PhD of Aggressive B-Cell Lymphoma into practice. This conference will focus on the most clinically- integrated approach toward clinical-pathological correlation Francisco Hernandez-Ilizaliturri, MD 1:00-1:15 Transition Break relevant research findings presented at recent national for patient management. events, in order to help practitioners better understand how to 8:40 Updates in the Management of Chronic LEUKEMIA/MYELODYSPLASTIC DISORDERS apply this new information to their own patients. ACCREDITATION Lymphocytic Leukemia and Other Program Chair: Elizabeth Griffiths, MD Low-Grade Lymphomas EDUCATIONAL OBJECTIVES AMA Roswell Park Cancer Institute is accredited by the Pallawi Torka, MD 1:15 Treatment Changes in the Risk Stratification and Accreditation Council for Continuing Medical Education Management of Acute Myeloid Leukemia Following this program, participants should be able to: (ACCME) to sponsor continuing medical education 9:10 The Role of Checkpoint Inhibitors in the Hetty Carraway, MD, MBA, FACP Management of Lymphoid Malignancies • Examine the changes being adapted in the clinical for physicians. Julio Chavez, MD 1:45 How to Incorporate Gene Sequencing in the management of less common types of aggressive Roswell Park Cancer Institute designates this live educational Day-to-Day Management of Patients with Diffuse Large B-Cell Lymphoma. activity for a maximum of 6.0 AMA PRA Category 1 Credits.TM 9:45-10:00 Break Myelodysplasia or AML • Appraise how the use of novel monoclonal antibody Physicians should claim only the credit commensurate with Elizabeth Griffiths, MD

targeting could change the treatment paradigm of CLL the extent of their participation in the activity. MYELOMA Program Chair: Philip McCarthy, MD 2:15 Updates in the Management of Patients patients, and patients with Low-Grade Lymphoma.  The University at Buffalo School of Pharmacy and with Myeloproliferative Disorders (MPD) Pharmaceutical Sciences is accredited by the Accreditation 10:00 • Discuss recent clinical studies evaluating the activity The Role of Bone Marrow Transplant and Swapna Thota, MD Council for Pharmacy Education as a provider of continuing of checkpoint inhibitors in lymphoid malignancies. Maintenance Strategies in Newly-Diagnosed pharmacy education. The “Hematological Malignancies Multiple Myeloma 2:45 Flow Cytometry in Hematopoietic Diseases Conference 2017: Incorporating Targeted Therapies in • Make recommendations regarding stem cell Philip McCarthy, MD Jerry Wong, MD, PhD Blood-Related Disorders” is a knowledge-based activity and cryopreservation after induction therapy. will award up to 5 contact hours of continuing pharmacy 10:30 Introduction to CART Therapy in Multiple 3:15 Closing Remarks education credit. • Examine MM treatments and CART Therapy. Myeloma and Other Hematological Malignancies Christine Ho, MD 3:30 Adjourn This education activity is pending approval by the American • Incorporate novel monoclonal antibodies in the AANP Association of Nurse Practitioners of up to 5.0 contact hours management of relapsed/refractory MM. 11:00 An Overview of Novel Agents for Patients of accredited education. with Multiple Myeloma Pallawi Torka, MD